List of works - Despina Fotiou

A review of the venous thrombotic issues associated with multiple myeloma

scientific article published on 27 May 2016

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

scientific article published on 27 February 2017

Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients

scientific article published on 03 November 2020

Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations

scientific article published on 03 April 2020

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction

scientific article published on 03 October 2020

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates

scientific article published on 10 January 2019

Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu

scientific article published on 02 March 2020

Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance

scientific article published on 23 August 2020

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma

scientific article published on 04 November 2020

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies

scientific article published on 19 July 2018

Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis

scientific article published on 01 December 2018

Emerging drugs for the treatment of Waldenström macroglobulinemia

scientific article published on 21 September 2020

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

scientific article published on 24 May 2018

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis

scientific article published on 31 January 2018

Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications

scientific article published on 23 January 2020

Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period

scientific article published on 07 May 2020

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: re

scientific article published on 07 November 2018

Next generation flow cytometry for MRD detection in patients with AL amyloidosis

scientific article published on 12 August 2020

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

scientific article published on 01 October 2019

Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy

scientific article published on 28 March 2017

Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause

scientific article published on 27 July 2020

Screening for Gaucher disease among patients with plasma cell dyscrasias

scientific article published on 30 September 2019

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma

scientific article published on 25 September 2020

The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents

scientific article published on 22 November 2017

The current role of BTK inhibitors in the treatment of Waldenstrom's Macroglobulinemia

scientific article published on 13 July 2020

Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis